23 December 2006 CINVENTION and Relisys Medical announce the extension of the existing Licence and Supply Agreement for marketing of a eluting and non-eluting coronary stent with a bioactive nanostructured carbon-composite coating with pro-healing properties. Relisys Medical focuses on receiving CE mark and enetering directly into the US market
02 August 2006 IDEA AG announces successful completion of its pivotal Ph III study in Europe and reacquisition of rights to the targeted analgesic IDEA-033 in North America